Xeroderma pigmentosum variant: 5 years of tumour suppression by etretinate.
Berth-Jones
J
J
Department of Dermatology, Leicester Royal Infirmary.
Cole
J
J
Lehmann
A R
AR
Arlett
C F
CF
Graham-Brown
R A
RA
D000368:Aged; D004260:DNA Repair; D005050:Etretinate / Q000627:therapeutic use*; D005153:Facial Neoplasms / Q000517:prevention & control; D006225:Hand; D006801:Humans; D008297:Male; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000517:prevention & control; D014983:Xeroderma Pigmentosum / Q000188:drug therapy* / Q000235:genetics
D005050:Etretinate